'Pegase' program for evaluation of autologous stem cell transplantation in breast cancer

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 1, 1996, Pages

  Gisselbrecht, C ^a   Viens, P ^a   Lotz, J P ^a   Biron, P ^a   Asselain, B ^a   Maraninchi, D ^a   Roche, H ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; AUTOGRAFT; BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHATIC METASTASIS; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029981080     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Chevallier B., Chollet P., Merrouche Y., et al. Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer. Journal of Clinical Oncology, 13, 8 : 1564-1571, 1995.
2. Gisselbrecht C, Lotz JP, Devaux Y, et al. Autologous bone marrow transplantation (ABMT) after high dose Cyclophosphamide, Mitoxantrone, Alkeran (CMA) in breast cancer. High dose chemotherapy and stem cell transplantation in solid tumors, Berlin, Proceedings Bone Marrow Transplantation, 1994.
3. Canal P, Attal M, Chatelut E, et al. Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Res., 53, 4850-4854, 1993.
4. Chevallier B, Bastit P, Graie Y, et al. The centre H. Becquerel studies in inflammatory breast cancer : combined modality approach in 178 patients. Br J Cancer, 67 : 594-601, 1993.
5. Legha SS, Buzdar AU, Smith TL, et al. Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann. Intern. Med. 1979 : 847-852, 1991.